SAN FRANCISCO, May 16, 2016 /PRNewswire/ -- Patients using
in-home life support and their clinicians are about to enjoy the
latest in home health technology, remote patient monitoring, thanks
to the world's first cellular, cloud-connected in-home life support
ventilators.
ResMed (NYSE:RMD) announced today at the American Thoracic
Society conference its plan to bring cloud connectivity and its
remote patient monitoring software, AirView™, to its Astral life
support ventilators, thereby increasing its global lead in number
of remotely monitored patients. Today ResMed has more than 2.5
million patients monitored through AirView.
Cloud connectivity will enable physicians and home medical
equipment providers (HMEs) to access key patient data in the cloud
to better manage and improve the outcomes of the thousands of
patients who currently rely on Astral life support ventilators at
home – all within ResMed's secure, HIPAA-compliant cloud network.
Clinicians will have the option of accessing the patient data via
AirView or through the ResMed Data Exchange where they may
integrate their own electronic medical records systems with
AirView.
"Cloud connectivity is a major factor in the future of
healthcare," said ResMed President of Healthcare Informatics, Raj
Sodhi. "We've seen the great impact that ResMed's AirView has had
on patient outcomes and business efficiencies related to managing
sleep apnea and other respiratory conditions.
"This technology will bring the same benefits to those patients
who rely on home life support and have other respiratory needs as
well. We're also looking to connect Inova
Labs' portable oxygen concentrators after acquiring that
company earlier this year."
Introduced in 2014, ResMed's Astral life support ventilators
offer unparalleled mobility and ease of use for patients suffering
from neuromuscular disease, chronic obstructive pulmonary disease
(COPD), and other adult and pediatric respiratory disorders. Astral
100 and Astral 150 life support ventilators offer the best
battery-to-weight ratio on the market with an eight-hour internal
battery, 24-hour battery life capability with external battery
connections, and a weight of only 7.1 pounds (3.2 kilograms).
Select customers are currently piloting cloud connectivity on
Astral devices; it's expected to be available widely later this
year. See all of our award-winning connected care devices at the
ATS conference, Booth #1127, May 15–17, 2016.
About ResMed
ResMed (NYSE:RMD) changes lives with
award-winning medical devices and cutting-edge cloud-based software
applications that better diagnose, treat and manage sleep apnea,
chronic obstructive pulmonary disease (COPD) and other chronic
diseases. ResMed is a global leader in connected care, with more
than 1 million patients remotely monitored every day. Our
5,000-strong team is committed to creating the world's best
tech-driven medical device company – improving quality of life,
reducing the impact of chronic disease, and saving healthcare costs
in more than 100 countries. Find more about ResMed at
ResMed.com, Facebook, Twitter and LinkedIn.
For
Media:
|
For
Investors:
|
Jayme
Rubenstein
|
Agnes Lee
|
Public Relations
Manager
|
Senior Director,
Investor Relations
|
O:
858-836-6798
|
O:
858-836-5971
|
news@resmed.com
|
investorrelations@resmed.com
|
Logo -
http://photos.prnewswire.com/prnh/20140310/LA79234LOGO-a
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/resmed-life-support-ventilators-to-join-worlds-largest-remote-patient-monitoring-network-300268498.html
SOURCE ResMed Inc.